Fox Chase Cancer Center

 

23rd Collaborative Group of the Americas on Inherited Colorectal Cancer Annual Meeting
Avatar

GI Cancer Risks Associated with Pathogenic Variants (PV) in the Ataxia Telangiectasia Mutated (ATM) Gene

By 23rd Collaborative Group of the Americas on Inherited Colorectal Cancer Annual Meeting FEATURING Michael Hall
By 23rd Collaborative Group of the Americas on Inherited Colorectal Cancer Annual Meeting FEATURING Michael Hall
27 views
December 10, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Featured Video

17:48
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh
Videos
19:18

New

Historical vs. Current Trends in mCRC Research: FIRE, CALGB/SWOG 804…

Fox Chase Cancer Center

V. Wookey

09:01

ASCO® GU 2025 Summary: Perioperative Strategies in MIBC - Key Trial …

Insights from 2025 ASCO® GU Annual Meeting

E. Plimack

249 views
09:27

Pirtobrutinib in R/R B-Cell Malignancies: Newest Data From the BRUIN…

Fox Chase Cancer Center

S. Nakhoda

83 views
06:32

ESMO 2024 Summary: Important GU Trials - EV-103 5-Year Follow-Up (la…

2024 ESMO Annual Meeting Insights Hub

E. Plimack

232 views
12:50

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-Paclitaxe…

2024 ASCO® Annual Meeting Insights Hub

E. Dotan

758 views
04:25

LS-SCLC Updates - 2023 ASCO® Direct Philadelphia

Total Health

J. Bauman

83 views
04:35

Chemo vs. Chemo + Pembro in 1L Pleural Mesothelioma - 2023 ASCO® Dir…

Total Health

J. Bauman

235 views
26:42

ADAURA & KEYNOTE-671 Trials: Early Stage NSCLC Updates - 2023 ASCO® …

Total Health

J. Bauman

400 views
06:11

EHA® 2023 Insights: "An Outpatient Model for Teclistamab Step-Up Dos…

Insights from 2023 EHA® Annual Meeting

A. Varshavsky-Yanovsky

281 views
21:34

The Evolving Role of Dual Checkpoint Inhibition in Advanced NSCLC

2023 Texas Lung Cancer Conference Coverage

H. Borghaei

121 views
03:05

ASCO GU 2023 Adjuvant Therapies in Renal Cell Carcinoma: Are New Dat…

ASCO GU 2023 Conference Coverage

M. Zibelman

266 views
13:51

Adjuvant Treatment of NSCLC: ADAURA in Context

Fox Chase Cancer Center

M. Edelman

556 views
09:51

Influence of 1L Chemo on Survival Outcomes of Patients with Advanced…

Fox Chase Cancer Center

B. Miron

110 views
08:35

2L Treatment of Advanced Gastric Cancer: Moving Towards an Opportuni…

Fox Chase Cancer Center

N. Vijayvergia

417 views
19:53

2021 Update on Advanced Urothelial Cancer: Navigating 1L and Beyond …

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

E. Plimack

47 views
12:36

Genotype-Directed Therapy for Advanced NSCLC: Overview of Targeted T…

3rd Annual Atlanta Precision Oncology Symposium

H. Borghaei

542 views
13:52

Targeted Therapy for Advanced NSCLC: Efficacy Analysis of RET, KRAS,…

3rd Annual Atlanta Precision Oncology Symposium

H. Borghaei

38 views
34:34

Immunology & IO in Lynch Syndrome: Immune System, MSI & Hereditary M…

UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics

M. J. Hall

114 views
16:08

Genomic Differentiation of Early-Onset CRC: When Should the Screenin…

Fox Chase Cancer Center

J. Meyer

331 views
08:15

2020 Update on Radiation Therapy in Lung Cancer: Is High-Dose Twice-…

2020 ASCO Virtual Direct™ Highlights

H. Borghaei

327 views
10:59

2020 ASCO Update on Targeted Therapy in NSCLC: Is Adjuvant Osimertin…

2020 ASCO Virtual Direct™ Highlights

H. Borghaei

440 views
03:24

2020 ASCO Update on Advanced RCC: Pembrolizumab + Axitinib vs. Sunit…

Fox Chase Cancer Center

E. Plimack

30 views
14:38

The Role of IO in Bladder Cancer: Potential Benefits in Neoadjuvant …

GRACE

E. Plimack, R. Sedhom

279 views
10:57

GI Cancer Risks Associated with Pathogenic Variants (PV) in the Atax…

23rd Collaborative Group of the Americas on Inherited Colorectal Cancer Annual Meeting

M. Hall

27 views
19:10

2019 1st Line Systemic Therapy for Metastatic Urothelial Carcinoma: …

Fox Chase Updates in Bladder and Kidney Cancer 2019

E. Plimack

446 views
14:23

Front Line Therapy in NSCLC: Immunotherapy vs Immunotherapy + Chemo?

Fox Chase Cancer Center

H. Borghaei

228 views
20:36

I-O/Chemo Combination Therapies in NSCLC

Fox Chase Cancer Center

H. Borghaei

298 views
09:14

Second Line Treatment Options in NSCLC

Fox Chase Cancer Center

H. Borghaei

395 views